Home › NDC Lookup › RxCUI directory › RxCUI 1727479

Alectinib 150 MG Oral Capsule — RxCUI 1727479

RxNorm drug concept · Semantic clinical drug
RxCUI 1727479 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1727479
Official nameAlectinib 150 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped1
Package NDCs mapped2
Reported Medicaid activity (SDUD)1,945 prescriptions · 20 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Alectinib: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It matters a lot, actually. Taking Alecensa with food — especially a meal with some fat in it — dramatically increases how much of the drug your body absorbs. Without food, you abs...
  • Why does it matter that I take Alecensa with food?
  • Mild constipation, muscle aches, fatigue, and some swelling are common and usually manageable — let your care team know, but these aren't emergencies. You should call your doctor r...
  • What side effects should I just watch for versus ones that mean I need to call my doctor right away?
📖 Read our full Alectinib guide →

🕸️ Concept Web — How Alectinib 150 MG Oral Capsule Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Alectinib 150 MG Oral Capsule RxCUI 1727479

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Alectinib 1727455
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Alecensa 1727480
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Alectinib Oral Capsule 1727478
    • Alectinib Oral Product 1727476
    • Alectinib Pill 1727477
    • Alectinib Oral Capsule [Alecensa] 1727482
    • Alecensa Oral Product 1727483
    • Alecensa Pill 1727484
    • Oral Capsule 316965
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Alectinib 150 MG SCDC · 1727475
  • Alectinib Oral Capsule SCDF · 1727478
  • Alectinib Oral Product SCDG · 1727476
  • Alectinib Pill SCDG · 1727477

Brand-Name Concepts

  • Alectinib 150 MG Oral Capsule [Alecensa] SBD · 1727485
  • Alectinib 150 MG [Alecensa] SBDC · 1727481
  • Alectinib Oral Capsule [Alecensa] SBDF · 1727482
  • Alecensa Oral Product SBDG · 1727483
  • Alecensa Pill SBDG · 1727484
  • Alecensa BN · 1727480

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 1727479 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
50242-0130-01 1 BOTTLE, PLASTIC in 1 CARTON (50242-130-01) / 240 CAPSULE... ALECENSA Genentech, Inc. 2015-12-11
50242-0130-86 1 BOTTLE, PLASTIC in 1 CARTON (50242-130-86) / 240 CAPSULE... ALECENSA Genentech, Inc. 2017-10-10
Observed labelers: Genentech, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.